NEONC TECHNOLOGIES HOLDINGS, INC.

Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.

NTHI | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 23975 PARK SORRENTO, 91302 CALABASAS
Website:: https://neonc.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company developing treatments for Central Nervous System (CNS) diseases, particularly brain cancers like glioblastoma. The company's core is a proprietary, patented platform technology featuring a novel intranasal drug delivery system designed to overcome the Blood-Brain Barrier (BBB). This technology facilitates the direct transport of new and established therapeutics to the brain, enhancing their potential efficacy. The company's pipeline includes candidates such as NEO100 and NEO212. NeOnc's platform offers a pathway for pharmaceutical companies to develop more effective treatments for challenging neurological conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NEONC TECHNOLOGIES HOLDINGS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NEONC TECHNOLOGIES HOLDINGS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for NEONC TECHNOLOGIES HOLDINGS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Alpha Cognition Inc. Develops and commercializes novel treatments for neurodegenerative diseases like Alzheimer's and ALS.	United States of America	ACOG
Alteogen Inc. Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.	South Korea	196170
ALTERITY THERAPEUTICS LTD Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.	United States of America	ATHE
Alto Neuroscience, Inc. Developing precision medicines for depression and schizophrenia using a brain biomarker platform.	United States of America	ANRO
ALUMIS INC. Develops targeted oral therapies for immune-mediated diseases using precision immunology.	United States of America	ALMS
Alvotech Develops and manufactures affordable biosimilar medicines for patients worldwide.	United States of America	ALVO
Alvotech Holdings S.A Develops and manufactures affordable biosimilar medicines for global patient access.	Luxembourg	ALVO
ALX ONCOLOGY HOLDINGS INC Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.	United States of America	ALXO
Alzamend Neuro, Inc. Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.	United States of America	ALZN
Alzinova AB Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.	Sweden	ALZ